Search details
1.
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
Ann Hematol
; 99(7): 1583-1594, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32506244
2.
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Ann Hematol
; 98(8): 1961-1972, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31065733
3.
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.
Leuk Lymphoma
; 57(5): 1094-103, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26293000
Results
1 -
3
de 3
1
Next >
>>